Highnoon Laboratories announced Financial Results for the period ended June 30, 2017.
The company’s Net Sales for the period increased by 12.75 percent in the outgoing year, whereas the Profit after Taxation for the Period increased by 17.09 percent.
Comparison of Key Financials
Unconsolidated Profit and Loss Account – For the Six Months Ended |
|||
Key Financials |
Jan – June, 2017 |
Jan – Jun, 2016 |
% Change |
Amounts in PKR ‘000 |
|||
Net Sales |
2,857,837,915 |
2,534,727,427 |
12.75% |
Cost of Sales |
1,460,114,048 |
1,316,732,326 |
10.89% |
Gross Profit |
1,397,723,867 |
1,217,995,101 |
14.76% |
Dist:, Selling and Promo: Expenses |
752,833,011 |
663,745,988 |
13.42% |
Admin: and General Expenses |
131,283,442 |
114,538,893 |
14.62% |
R&D Expenses |
1,816,843 |
1,626,054 |
11.73% |
Other Operating Expenses |
44,945,909 |
38,338,786 |
17.23% |
Operating Profit |
466,844,662 |
399,745,380 |
16.79% |
Other Income |
13,730,982 |
8,406,682 |
63.33% |
Finance Costs |
2,353,126 |
3,271,006 |
-28.06% |
Profit before Taxation |
478,222,518 |
404,881,056 |
18.11% |
Taxation |
161,028,030 |
133,974,995 |
20.19% |
PAT |
317,194,488 |
270,906,061 |
17.09% |
EPS – Basic and Diluted |
12.42 |
10.61 |
17.06% |
Company release on Earnings Report can be accessed here.